Dry Eye Disease

In the second part of a five-part series, Elizabeth Yeu, MD, discusses remote learning, the incorporation of technology in education, and how dry eye disease and symptomatology are affected.

In the field of ophthalmology and optometry, dry eye disease has been anything but delightful, fun or mesmerizing.

In the first part of a five-part series, Elizabeth Yeu, MD, FACS, discusses some of the ways the modern workplace can affect and exacerbate eye diseases and offers tips for relief for those who experience increased symptoms.

Rapid growth of knowledge and treatment advances in dry eye disease have evolved in parallel over the last 10 years.

Dry eye disease doctor friend: “What’s your take on the new dry eye spray?”

BOSTON — Symptoms of ocular surface disease in children were higher than previously seen and could be linked to increased screen time during the pandemic, according to a study presented in a poster at the American Academy of Optometry annual meeting.

In this episode, David W. Parke II, MD, sits down with hosts, Jim Mazzo and John A. Hovanesian, MD, FACS, to discuss stepping down as the AAO CEO, the highlights of what he accomplished during this time, and thoughts on the future of ophthalmology.

Good morning from Jerusalem! It’s precisely “next year” today.

TearClear has initiated a phase 3 trial evaluating TC-002, a preservative-free latanoprost ophthalmic solution, in patients with glaucoma, according to a press release.

The FDA has approved the first generic version of Restasis, according to a press release.